Virtual Meeting to be held on July 9 hosted by B. Riley.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUVB:
- Nuvation Bio’s Strategic Positioning and Financial Strength Justify Buy Rating
- Nuvation Bio announces taletrectinib as preferred agent in NCCN Guidelines
- Nuvation Bio price target lowered to $6 from $10 at RBC Capital
- Buy Rating for Nuvation Bio’s IBTROZI: FDA Approval and Competitive Edge in ROS1+ NSCLC Treatment
- Nuvation Bio’s IBTROZI Receives FDA Approval